S3 Guidelines: Epicutaneous patch testing with contact allergens and drugs - Short version, Part 2.
Allergens
/ adverse effects
Child
Consensus
Dermatitis, Allergic Contact
/ diagnosis
Dermatologists
Female
Humans
Hypersensitivity, Delayed
/ immunology
Immunocompromised Host
/ immunology
Nursing Staff
Occupational Medicine
Patch Tests
/ adverse effects
Pediatricians
Practice Guidelines as Topic
Pregnancy
Journal
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
entrez:
26
11
2019
pubmed:
26
11
2019
medline:
2
10
2020
Statut:
ppublish
Résumé
Epicutaneous patch testing is the diagnostic standard for the detection of allergic contact dermatitis. The present guidelines are aimed at residents and board-certified physicians in the fields of dermatology and allergology as well as other medical specialties involved in establishing the indication for patch testing and its execution in patients with contact dermatitis and other forms of delayed-type hypersensitivity. The target audience also includes other health care providers and insurance funds. Based on a systematic literature search and a formal consensus process (S3), the guidelines were developed by dermatologists in collaboration with pediatricians, occupational medicine physicians, nursing staff as well as patient representatives. The systematic methodological approach and appraisal of evidence upon which the recommendations are based are outlined in a separate method report that also contains evidence tables. The guidelines address general aspects of patch testing as well as medicolegal issues. The recommendations given relate to topics such as the indication for patch testing, informed patient consent, as well as the choice of test substances, test chambers and test site, duration of exposure, reading times and interpretation of test reactions. Furthermore, recommendations are provided with respect to endogenous and exogenous factors, specific patient groups (children, pregnant women, immunosuppressed individuals) as well as possible risks and adverse events associated with patch testing using contact allergens.
Substances chimiques
Allergens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1187-1207Informations de copyright
© 2019 The Authors | Journal compilation © Blackwell Verlag GmbH, Berlin.
Références
Agner T, Damm P, Skouby SO. Menstrual cycle and skin reactivity. J Am Acad Dermatol 1991; 24: 566-70.
Kemmett D. Premenstrual exacerbation of atopic dermatitis. Br J Dermatol 1989; 120: 715.
Raghunath RS, Venables ZC, Millington GW. The menstrual cycle and the skin. Clin Exp Dermatol 2015; 40: 111-5.
Stephens CJ. Perimenstrual eruptions. Clin Dermatol 1997; 15: 31-4.
Yell JA, Burge SM. The effect of hormonal changes on cutaneous disease in lupus erythematosus. Br J Dermatol 1993; 129: 18-22.
Burton JL, Cartlidge M, Shuster S. Variations in sebum excretion during the menstrual cycle. Acta Derm Venereol 1973; 53: 81-4.
Farage MA, Berardesca E, Maibach H. The possible relevance of sex hormones on irritant and allergic responses: their importance for skin testing. Contact Dermatitis. 2010; 62: 67-74.
Myers MJ, Butler LD, Petersen BH. Estradiol-induced alteration in the immune system. II. Suppression of cellular immunity in the rat is not the result of direct estrogenic action. Immunopharmacology 1986; 11: 47-55.
Shah MG, Maibach HI. Estrogen and skin. An overview. Am J Clin Dermatol 2001; 2: 143-50.
Alexander S. Patch testing and menstruation. Lancet 1988; 2: 751.
Gordon BD. Patch testing and the menstrual cycle. J Am Acad Dermatol 1991; 24: 152-3.
Aktan S, Aktan E, Inanir I et al. Reproducibility of the Finn chamber nickel patch test in two different phases of the ovulatory menstrual cycle. Dermatology 1998; 197: 235-7.
Bonamonte D, Foti C, Antelmi AR et al. Nickel contact allergy and menstrual cycle. Contact Dermatitis 2005; 52: 309-13.
Hindsen M, Bruze M, Christensen OB. Individual variation in nickel patch test reactivity. Am J Contact Dermat 1999; 10: 62-7.
Rohold AE, Halkier-Sorensen L, Andersen KE, Thestrup-Pedersen K. Nickel patch test reactivity and the menstrual cycle. Acta Derm Venereol 1994; 74: 383-5.
Tamer E, Ikizoglu G, Toy GG, Alli N. Comparison of nickel patch test reactivity in phases of the menstrual cycle. Int J Dermatol 2003; 42: 455-8.
McLelland J, Lawrence CM. Premenstrual exacerbation of nickel allergy. Br J Dermatol 1991; 125: 83.
Rustemeyer T, van Hoogstraten IM, von Blomberg BME et al. Mechanisms of irritant and allergic contact dermatitis. Contact dermatitis: Springer 2011: 43-90.
Anveden I, Lindberg M, Andersen KE et al. Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis 2004; 50: 298-303.
Feuerman E, Levy A. A study of the effect of prednisone and an antihistamine on patch test reactions. Br J Dermatol 1972; 86: 68-71.
O'Quinn SE, Isbell KH. Influence of oral prednisone on eczematous patch test reactions. Arch Dermatol 1969; 99: 380-9.
Condie MW, Adams RM. Influence of oral prednisone on patch-test reactions to Rhus antigen. Arch Dermatol 1973; 107: 540-3.
Clark RA, Rietschel RL. 0.1 % triamcinolone acetonide ointment and patch test responses. Arch Dermatol 1982; 118: 163-5.
Green C. The effect of topically applied corticosteroid on irritant and allergic patch test reactions. Contact Dermatitis 1996; 35: 331-3.
Smeenk G. Influence of local triamcinolone acetonide on patch test reactions to nickel sulfate. Dermatologica 1975; 150: 116-21.
Sukanto H, Nater JP, Bleumink E. Influence of topically applied corticosteroids on patch test reactions. Contact Dermatitis 1981; 7: 180-5.
De Silva BD, Yong GSY, Wells J. How should we be advising patients regarding the use of topical steroids prior to patch tests? Brit J Dermatol 1999; 141: 91-2.
Grob JJ, Castelain M, Richard MA et al. Antiinflammatory properties of cetirizine in a human contact dermatitis model. Clinical evaluation of patch tests is not hampered by antihistamines. Acta Derm Venereol 1998; 78: 194-7.
Motolese A, Ferdani G, Manzini BM, Seidenari S. Echographic evaluation of patch test inhibition by oral antihistamine. Contact Dermatitis 1995; 32: 250-1.
Stingeni L, Agostinelli D. Antihistamines and patch test. Annali italiani di dermatologia allergologica, clinica e sperimentale 2001; 55: 88-92.
Sherertz EF. The effect of oral ibuprofen on patch test reactivity in subjects allergic to poison ivy/oak. J Am Acad Dermatol 1997; 36: 647-9.
Verma KK, Bhari N, Sethuraman G. Azathioprine does not influence patch test reactivity in Parthenium dermatitis. Contact Dermatitis 2016; 74: 64-5.
Higgins EM, McLelland J, Friedmann PS et al. Oral cyclosporin inhibits the expression of contact hypersensitivity in man. J Dermatol Sci 1991; 2: 79-83.
Quemeneur L, Michallet MC, Ferraro-Peyret C et al. Immunosuppressive antimetabolites inhibit induction of contact hypersensitivity while lymphoablative drugs also prevent its expression. Eur J Dermatol 2003; 13: 540-7.
Pigatto P, Cesarani A, Barozzi S, Guzzi G. Positive response to nickel and azathioprine treatment. J Eur Acad Dermatol Venereol 2008; 22: 891.
Rosmarin D, Gottlieb AB, Asarch A, Scheinman PL. Patch-testing while on systemic immunosuppressants. Dermatitis 2009; 20: 265-70.
Wee JS, White JM, McFadden JP, White IR. Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors. Contact Dermatitis 2010; 62: 165-9.
Balato N, Patruno C, Lembo G et al. Effect of pentoxifylline on patch test response. Contact Dermatitis 1996; 34: 153.
Schwarz T, Schwarz A, Krone C, Luger TA. Pentoxifylline suppresses allergic patch test reactions in humans. Arch Dermatol 1993; 129: 513-4.
Anonymus. Fachinfo-Service 2016. Available from: http://www.fachinfo.de [Last accessed January 10, 2019].
Basketter DA, Griffiths HA, Wang XM et al. Individual, ethnic and seasonal variability in irritant susceptibility of skin: the implications for a predictive human patch test. Contact Dermatitis 1996; 35: 208-13.
Bruze M. Seasonal influence on routine patch test results. Contact Dermatitis 1986; 14: 184.
Dooms-Goossens A, Lesaffre E, Heidbuchel M et al. UV sunlight and patch test reactions in humans. Contact Dermatitis 1988; 19: 36-42.
Edman B. Seasonal influence on patch test results. Contact Dermatitis 1989; 20: 226.
Hegewald J, Uter W, Kranke B et al. Patch test results with metals and meteorological conditions. Int Arch Allergy Immunol 2008; 147: 235-40.
Hegewald J, Uter W, Kranke B et al. Meteorological conditions and the diagnosis of occupationally related contact sensitizations. Scand J Work Environ Health 2008; 34: 316-21.
Katsarou A, Kalogeromitros D, Armenaka M et al. The influence of climatic factors on patch test results in Athens. Contact Dermatitis 1993; 28: 301-2.
Kranke B, Aberer W. Seasonal influence on patch test results in central Europe. Contact Dermatitis 1996; 34: 215-6.
Loffler H, Happle R. Influence of climatic conditions on the irritant patch test with sodium lauryl sulphate. Acta Derm Venereol 2003; 83: 338-41.
Uter W, Geier J, Land M et al. Another look at seasonal variation in patch test results. A multifactorial analysis of surveillance data of the IVDK. Information Network of Departments of Dermatology. Contact Dermatitis 2001; 44: 146-52.
Uter W, Hegewald J, Kranke B et al. The impact of meteorological conditions on patch test results with 12 standard series allergens (fragrances, biocides, topical ingredients). Br J Dermatol 2008; 158: 734-9.
Uter W, Hegewald J, Pfahlberg A et al. The association between ambient air conditions (temperature and absolute humidity), irritant sodium lauryl sulfate patch test reactions and patch test reactivity to standard allergens. Contact Dermatitis 2003; 49: 97-102.
Hosoi J, Hariya T, Denda M, Tsuchiya T. Regulation of the cutaneous allergic reaction by humidity. Contact Dermatitis 2000; 42: 81-4.
Agner T, Serup J. Seasonal variation of skin resistance to irritants. Br J Dermatol 1989; 121: 323-8.
John SM, Uter W. Meteorological influence on NaOH irritation varies with body site. Arch Dermatol Res 2005; 296: 320-6.
Uter W, Gefeller O, Schwanitz HJ. An epidemiological study of the influence of season (cold and dry air) on the occurrence of irritant skin changes of the hands. Br J Dermatol 1998; 138: 266-72.
Geier J, Uter W, Pirker C, Frosch PJ. Patch testing with the irritant sodium lauryl sulfate (SLS) is useful in interpreting weak reactions to contact allergens as allergic or irritant. Contact Dermatitis 2003; 48: 99-107.
Hannuksela M, Salo H. The repeated open application test (ROAT). Contact Dermatitis 1986; 14: 221-7.
Johansen JD, Frosch PJ, Menné T. Allergic contact dermatitis in humans - experimental and quantitative aspects. Contact Dermatitis: Springer 2006: 189-98.
Loffler H, Becker D, Brasch J, Geier J. Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG). Br J Dermatol 2005; 152: 709-19.
Geier J, Weisshaar E, Lessmann H. Bewertung von Epikutantestreaktionen auf “Problemallergene” mit vermehrt fraglichen oder schwach positiven Reaktionen. Dermatologie in Beruf und Umwelt 2010; 58: 34-8.
Damian DL, Halliday GM. Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans. Methods 2002; 28: 34-45.
Kalimo K, Koulu L, Jansen CT. Effect of a single UVB or PUVA exposure on immediate and delayed skin hypersensitivity reactions in humans. Correlation to erythemal response and Langerhans cell depletion. Arch Dermatol Res 1983; 275: 374-8.
Matthews YJ, Halliday GM, Phan TA, Damian DL. A UVB wavelength dependency for local suppression of recall immunity in humans demonstrates a peak at 300 nm. J Invest Dermatol 2010; 130: 1680-4.
Phan TA, Halliday GM, Barnetson RS, Damian DL. Spectral and dose dependence of ultraviolet radiation-induced immunosuppression. Front Biosci 2006; 11: 394-411.
Sjovall P, Christensen OB. Local and systemic effect of ultraviolet irradiation (UVB and UVA) on human allergic contact dermatitis. Acta Derm Venereol 1986; 66: 290-4.
Spier HW, Natzel R. Chromatallergie und Zementekzem. Gewerbedermatologischer und analytischer Beitrag. Hautarzt 1953; 4: 63-5.
Spier HW, Sixt I. Untersuchungen über die Abhängigkeit des Ausfalles der Ekzem-Läppchenproben von der Hornschichtdicke. Quantitativer Abriß-Epikutantest. Hautarzt 1955; 6: 152-9.
Lachapelle JM, Maibach HI. Additional testing procedures. In: Lachapelle JM , Maibach HI : Patch Testing and Prick Testing. 1st ed. Berlin Heidelberg New York: Springer-Verlag 2003: 111-20.
Dickel H, Bruckner TM, Erdmann SM et al. The “strip” patch test: results of a multicentre study towards a standardization. Arch Dermatol Res 2004; 296: 212-9.
Dickel H, Altmeyer P, Brasch J. „Neue” Techniken für eine sensitivere Epikutantestung? [“New” techniques for more sensitive patch testing?]. J Dtsch Dermatol Ges 2011; 9: 889-96.
Dickel H, Goulioumis A, Gambichler T et al. Standardized tape stripping: a practical and reproducible protocol to uniformly reduce the stratum corneum. Skin Pharmacol Physiol 2010; 23: 259-65.
Dickel H, Gambichler T, Kamphowe J et al. Standardized tape stripping prior to patch testing induces upregulation of Hsp90, Hsp70, IL-33, TNF-α and IL-8/CXCL8 mRNA: new insights into the involvement of ‘alarmins'. Contact Dermatitis 2010; 63: 215-22.
Dickel H, Kreft B, Kuss O et al. Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicenter diagnostic accuracy study. Contact Dermatitis 2010; 62: 294-302.
Dickel H, Kamphowe J, Geier J et al. Strip patch test vs. conventional patch test: investigation of dose-dependent test sensitivities in nickel- and chromium-sensitive subjects. J Eur Acad Dermatol Venereol 2009; 23: 1018-25.
Dickel H, Kreft B, Geier J. Strip patch testing does not affect reaction profiles of standard allergens. Contact Dermatitis 2015; 73: 36-43.
Scola N, Hunzelmann N, Ruzicka T et al. Positive Testreaktionen im Abrissepikutantest bei negativem Standardepikutantest. Bedeutung für die berufsdermatologische Begutachtung. [Positive strip patch test reactions with coexistent negative patch test reactions. Relevance for the assessment practice of occupational skin disease]. Hautarzt 2010; 61: 1056-60.
Dickel H, Scola N, Altmeyer P. The strip patch test - indication in occupational dermatology demonstrated with a case history. [Der Abriss-Epikutantest - Indikation in der Berufsdermatologie anhand eines Fallbeispiels]. J Dtsch Dermatol Ges 2009; 11: 965-7.
Veien NK, Kaaber K. Nickel, cobalt and chromium sensitivity in patients with pompholyx (dyshidrotic eczema). Contact Dermatitis 1979; 5: 371-4.
Trautmann A. Delayed-type heparin hypersensitivity: subcutaneous allergy and intravenous tolerance. Asthma Allergy Immunol 2009; 7: 147-53.
Frosch P, Schnuch A, Uter W. Kontaktdermatitis - Ein Leitfaden für die Praxis unter besonderer Berücksichtigung von Berufsdermatosen. 1st Edition. Dustri-Verlag Dr. Karl Feistle, München-Deisenhofen Berlin, 2014.
Brasch J. Mundschleimhaut und Kontaktallergie. Allergo J 2004; 13: 191-7.
Koch P. Allergic contact dermatitis due to timolol and levobunolol in eyedrops, with no cross-sensitivity to other ophthalmic beta-blockers. Contact Dermatitis 1995; 33: 140-1.
Schneider W. Diskussionsäußerungen, Fragen aus dem Leserkreise, Anfrage Nr. 2: “Prognostische, diagnostische und gutachtliche Bedeutung von Hauttesten in der Gewerbemedizin. Ich denke dabei vor allem an lipoid-lösliche Substanzen.”, 2. Stellungnahme. Dermatologische Gutachten - Beiträge zur Praxis der Berufsdermatosen 1952; 1: 154-6.
Spier HW. Allgemeine Gesichtspunkte zur Begutachtung von Gewerbedermatosen. Berufsdermatosen 1954; 2: 194-9.
Prue C, Martinson ME, McAnally PM, Stagner WC. Postmarketing survey results of T.R.U.E. TEST, a new allergen patch test. Am J Contact Dermat 1998; 9: 6-10.
Inerot A, Moller H. Symptoms and signs reported during patch testing. Am J Contact Dermat 2000; 11: 49-52.
Jacob SE, Herro EM, Sullivan K et al. Safety and efficacy evaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescents. Dermatitis 2011; 22: 204-10.
Mancuso G, Berdondini RM, Cavrini G. Long-lasting allergic patch test reactions: a study of patients with positive standard patch tests. Contact Dermatitis 1999; 41: 35-9.
Isaksson M, Lindberg M, Sundberg K et al. The development and course of patch-test reactions to 2-hydroxyethyl methacrylate and ethyleneglycol dimethacrylate. Contact Dermatitis 2005; 53: 292-7.
Kanerva L, Estlander T. Contact leukoderma caused by patch testing with dental acrylics. Am J Contact Dermat 1998; 9: 196-8.
Bordel-Gomez MT, Miranda-Romero A. [Post-traumatic basal cell carcinoma associated with patch testing]. Actas Dermosifiliogr 2009; 100: 606-10.
Moller H, Spiren A, Svensson A et al. Contact allergy to the Asteraceae plant Ambrosia artemisiifolia L (ragweed) in sesquiterpene lactone-sensitive patients in southern Sweden. Contact Dermatitis 2002; 47: 157-60.
Jovanovic M, Mimica-Dukic N, Poljacki M, Boza P. Erythema multiforme due to contact with weeds: a recurrence after patch testing. Contact Dermatitis 2003; 48: 17-25.
Reig Rincon de Arellano I, Villalon Garcia AL, Cimarra Alvarez-Lovell M et al. Flare up to betalactams. Allergol Immunopathol (Madr) 2005; 33: 282-4.
Isaksson M, Bruze M. Allergic contact dermatitis in response to budesonide reactivated by inhalation of the allergen. J Am Acad Dermatol 2002; 46: 880-5.
Lauerma AI, Reitamo S, Maibach HI. Systemic hydrocortisone/cortisol induces allergic skin reactions in presensitized subjects. J Am Acad Dermatol 1991; 24: 182-5.
Moller H, Larsson A, Bjorkner B et al. Flare-up at contact allergy sites in a gold-treated rheumatic patient. Acta Derm Venereol 1996; 76: 55-8.
O'Donnell BF, Tan CY. Erythema multiforme reaction to patch testing. Contact Dermatitis 1992; 27: 230-4.
Mashiah J, Brenner S. A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol 2003; 139: 1181-3.
Perfetti L, Galdi E, Biale C et al. Anaphylactoid reaction to patch testing with ammonium persulfate. Allergy 2000; 55: 94-5.
Vigan M, Girardin P, Adessi B, Laurent R. Late reading of patch tests. Eur J Dermatol 1997; 7: 574-6.
Hillen U, Frosch PJ, John SM et al. Patch test sensitization caused by para-tertiary-butylcatechol. Results of a prospective study with a dilution series. Contact Dermatitis 2001; 45: 193-6.
Hillen U, Jappe U, Frosch PJ et al. Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group. Br J Dermatol 2006; 154: 665-70.
Paulsen E, Andersen KE, Hausen BM. An 8-year experience with routine SL mix patch testing supplemented with Compositae mix in Denmark. Contact Dermatitis 2001; 45: 29-35.
Arnold WP, van Joost T, van Der Valk PG. Adding p-aminoazobenzene may increase the sensitivity of the European standard series in detecting contact allergy to dyes, but carries the risk of active sensitization. Contact Dermatitis 1995; 33: 444.
Kanerva L, Estlander T, Jolanki R. Double active sensitization caused by acrylics. Dermatitis 1992; 3: 23-6.
Mahler V, Dickel H, Diepgen TL et al. Stellungnahme der Deutschen - Kontaktallergie-Gruppe (DKG) und der Deutschen Dermatologischen Gesellschaft (DDG) zu haftungsrechtlichen Konsequenzen bei der Epikutantestung mit patienteneigenem Material. J Dtsch Dermatol Ges 2017; 15: 202-4.
Worm M, Aberer W, Agathos M et al. Epikutantestung bei Kindern - Empfehlungen der Deutschen Kontaktallergiegruppe (DKG). J Dtsch Dermatol Ges 2007; 5(2): 107-9.
Stables GI, Forsyth A, Lever RS. Patch testing in children. Contact Dermatitis 1996; 34: 341-4.
Heine G, Schnuch A, Uter W, Worm M. Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group. Contact Dermatitis 2004; 51: 111-7.
Simonsen AB, Deleuran M, Mortz CG et al. Allergic contact dermatitis in Danish children referred for patch testing - a nationwide multicentre study. Contact Dermatitis 2014; 70: 104-11.
Silny W, Bartoszak L, Jenerowicz D et al. Prevalence of contact allergy in children suffering from atopic dermatitis, seborrhoeic dermatitis and in healthy controls. Ann Agric Environ Med 2013; 20: 55-60.
Ho SG, White IR, Rycroft RJ, McFadden JP. A new approach to patch testing patients with para-phenylenediamine allergy secondary to temporary black henna tattoos. Contact Dermatitis 2004; 51: 213-4.
Spornraft-Ragaller P, Kammerer E, Gillitzer C, Schmitt J. Severe allergic reactions to para-phenylenediamine in children and adolescents: should the patch test concentration of PPD be changed? J Dtsch Dermatol Ges 2012; 10: 258-64.
Spornraft-Ragaller P, Schnuch A, Uter W. Extreme patch test reactivity to p-phenylenediamine but not to other allergens in children. Contact Dermatitis 2011; 65: 220-6.
Mehl A, Rolinck-Werninghaus C, Staden U et al. The atopy patch test in the diagnostic workup of suspected food-related symptoms in children. J Allergy Clin Immunol 2006; 118: 923-9.
Turjanmaa K, Darsow U, Niggemann B et al. EAACI/GA2LEN position paper: present status of the atopy patch test. Allergy 2006; 61: 1377-84.
Niggemann B, Beyer K. Diagnosis of food allergy in children: toward a standardization of food challenge. J Pediatr Gastroenterol Nutr 2007; 45: 399-404.
Werfel T, Heratizadeh A, Aberer W et al. S2k guideline on diagnosis and treatment of atopic dermatitis - short version. J Dtsch Dermatol Ges 2016; 14: 92-106.
Worm M, Reese I, Ballmer-Weber B et al. Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional Association of Pediatricians (BVKJ), the German Allergy and Asthma Association (DAAB), German Dermatological Society (DDG), the German Society for Nutrition (DGE), the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS), the German Society for Oto-Rhino-Laryngology, Head and Neck Surgery, the German Society for Pediatric and Adolescent Medicine (DGKJ), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Society for Pneumology (DGP), the German Society for Pediatric Gastroenterology and Nutrition (GPGE), German Contact Allergy Group (DKG), the Austrian Society for Allergology and Immunology (AE-GAI), German Professional Association of Nutritional Sciences (VDOE) and the Association of the Scientific Medical Societies Germany (AWMF). Allergo J Int 2015; 24: 256-93.
Shear NH, Milpied B, Bruynzeel DP, Phillips EJ. A review of drug patch testing and implications for HIV clinicians. AIDS 2008; 22: 999-1007.
Mallal S, Phillips E, Carosi G et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008; 358: 568-79.
Saag M, Balu R, Phillips E et al. High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clin Infect Dis 2008; 46: 1111-8.
Treudler R, Husak R, Raisova M et al. Efavirenz-induced photoallergic dermatitis in HIV. AIDS 2001; 15: 1085-6.
Yoshimoto E, Konishi M, Takahashi K et al. The first case of efavirenz-induced photosensitivity in a Japanese patient with HIV infection. Intern Med 2004; 43: 630-1.
Verma R, Vasudevan B, Shankar S et al. First reported case of tenofovir-induced photoallergic reaction. Indian J Pharmacol 2012; 44: 651-3.
Rietmeijer CA, Cohn DL. Severe allergic contact dermatitis from dinitrochlorobenzene in a patient with human immunodeficiency virus infection. Arch Dermatol 1988; 124: 490-1.
Finesmith TH, Seaman S, Rietschel R. Paradoxical coexistence of contact dermatitis and anergy in a man with AIDS. J Am Acad Dermatol 1995; 32: 526-7.
Bellegrandi S, D'Offizi G, Ansotegui IJ et al. Propolis allergy in an HIV-positive patient. J Am Acad Dermatol 1996; 35: 644.
Bellegrandi S, Rosso R, Mattiacci G et al. Contact dermatitis in subjects infected with HIV type 1. J Am Acad Dermatol 1999; 40: 777-9.
Curr N, Nixon R. Allergic contact dermatitis to basic red 46 occurring in an HIV-positive patient. Australas J Dermatol 2006; 47: 195-7.
Smith KJ, Skelton HG, Nelson A et al. Preservation of allergic contact dermatitis to poison ivy (urushiol) in late HIV disease. The implications and relevance to immunotherapy with contact allergens. Dermatology 1997; 195: 145-9.
Kardaun SH, de Waard MM, de Monchy JG. Flare-up of patch test of trimethoprim-sulfamethoxazole (co-trimoxazole) during oral desensitization. Contact Dermatitis 2009; 61: 50-1.
Shebe K, Ngwanya MR, Gantsho N, Lehloenya RJ. Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man. Contact Dermatitis 2014; 70: 125-7.
Gompels MM, Simpson N, Snow M et al. Desensitization to co-trimoxazole (trimethoprim-sulphamethoxazole) in HIV-infected patients: is patch testing a useful predictor of reaction? J Infect 1999; 38: 111-5.
Anonymus. Patienten-Aufklärung über die allergologische Diagnostik mit dem Epikutantest. Available from: https://dkg.ivdk.org/dok/PatientenAufklaerung_ECT_Patchtest_2017_10_30.pdf [Last accessed January 1, 2019].
Anonymus. Cosing Datenbank der EU-Kommission. Available from: https://ec.europa.eu/growth/sectors/cosmetics/cosing_en [Last accessed January 1, 2019].
Anonymus. Bewusster Leben mit Kontaktallergien (Ratgeber). Available from: http://www.haut.de/wp-content/uploads/daab_ratgeber_kontaktallergie.pdf. [Last accessed January 1, 2019].